Temozolomide treatment leads to alterations in mismatch repair genes and can be followed by response to immune checkpoint blockade in colorectal cancer patients. Temozolomide treatment leads to alterations in mismatch repair genes and can be followed by response to immune checkpoint blockade in colorectal cancer patients
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Temozolomide treatment leads to alterations in mismatch repair genes and can be followed by response to immune checkpoint blockade in colorectal cancer patientsONLY CELL LINES DATA were submitted
创建时间：
2022-01-05
